| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.53 | 0.06 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.092 | 0.07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |